APA (7th ed.) Citation

Anastasilakis, A. D., Polyzos, S. A., Yavropoulou, M. P., Appelman-Dijkstra, N. M., Ntenti, C., Mandanas, S., . . . Makras, P. (2021). Comparative Effect of Zoledronate at 6 Versus 18 Months Following Denosumab Discontinuation. Calcified Tissue International, 108(5), 587. https://doi.org/10.1007/s00223-020-00785-1

Chicago Style (17th ed.) Citation

Anastasilakis, Athanasios D., Stergios A. Polyzos, Maria P. Yavropoulou, Natasha M. Appelman-Dijkstra, Charikleia Ntenti, Stylianos Mandanas, Athanasios Papatheodorou, and Polyzois Makras. "Comparative Effect of Zoledronate at 6 Versus 18 Months Following Denosumab Discontinuation." Calcified Tissue International 108, no. 5 (2021): 587. https://doi.org/10.1007/s00223-020-00785-1.

MLA (9th ed.) Citation

Anastasilakis, Athanasios D., et al. "Comparative Effect of Zoledronate at 6 Versus 18 Months Following Denosumab Discontinuation." Calcified Tissue International, vol. 108, no. 5, 2021, p. 587, https://doi.org/10.1007/s00223-020-00785-1.